Artificial intelligence (AI), deep learning (DL), and machine learning (ML) have transformed many industries and areas of science. Now, these tools are being applied to address the challenges of cancer biomarker discovery, ...
Mar 2, 2022
0
265
Approximately 700 people are diagnosed with diffuse large B-cell lymphoma (DLBCL) in Finland each year. It is the most common cancer that originates from lymphocytes, immune system cells. Although the disease is treated with ...
Feb 21, 2022
0
7
Hyaluronic acid, or HA, is a known presence in pancreatic tumors, but a new study from researchers at the University of Michigan Health Rogel Cancer Center shows that hyaluronic acid also acts as food to the cancer cells. ...
Jan 27, 2022
0
113
Researchers led by Prof. Dai Jianwu from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences developed a multifunctional scaffold to effectively regulate the immune microenvironment after ...
Jan 13, 2022
0
26
Over the past few decades, scientists have made great strides in understanding the genetic mutations that can drive cancer. For some types of cancer, these discoveries have led to the development of drugs that target specific ...
Dec 9, 2021
0
17
A next-generation technology that allows the study of protein expression at the single-cell level and the location of the cells within the tumor microenvironment (TME) was feasible and provided information on the benefit ...
Dec 7, 2021
0
9
In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach. It is based on using humanized antibodies called immune checkpoint inhibitors (ICIs) to block the cellular pathways ...
Dec 7, 2021
0
56
Cells from the immune system called CD4+ regulatory T cells, or simply Treg, are linked to tumor prognosis: the more Treg cells present in a tumor, the worst the prognosis. We know from previous research studies that Treg ...
Nov 29, 2021
0
1
New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated with improved responses to immune checkpoint inhibitors. The ...
Nov 24, 2021
0
1360
New Cleveland Clinic research has found that drugs originally designed to help treat Alzheimer's disease may hold promise for glioblastoma, the most common and lethal type of primary brain tumor. The findings were published ...
Nov 23, 2021
0
60
